Thu, Aug 21, 2014, 9:38 AM EDT - U.S. Markets close in 6 hrs 22 mins


% | $
Quotes you view appear here for quick access.

Johnson & Johnson Message Board

crecy_war_knight 261 posts  |  Last Activity: Aug 18, 2014 11:15 AM Member since: Jan 25, 2007
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Its now riskier to short than to buy & hold.

  • Reply to

    What does Management need to do ?

    by crecy_war_knight Aug 14, 2014 12:07 PM
    crecy_war_knight crecy_war_knight Aug 14, 2014 1:00 PM Flag

    Afrezza....will only get about 1% of the diabetic market and sales could be VERY DISAPPOINTING. But good company fundamentals could keep this stock from a future huge DUMP when the first Q sales are announced.

  • crecy_war_knight by crecy_war_knight Aug 14, 2014 12:07 PM Flag

    They must increase SHAREHOLDER VALUE- they don't seem to remember that concept.

    Must not issue more shares for at least 1 year
    Must pay off some debt
    Continue to stay on all 4 cylinders with their R&D
    Avoid excessive bonus and compensation
    Top-down Critical review & consolidation of all major costs & spending
    Reach out for other partners to develop more revenue streams
    Critical review and monitoring of all current revenue streams

    Most likely the company is already doing many of these steps and more, but I think they need to go back to the drawing board and take another look at their internal processes. They have succeeded and failed. They need to recognize that despite their great success in bringing Afrezza to approval they have also failed to bring value to the shareholders. Why? The company fundamental have come back to haunt them. As long as they place their "success " above basic company fundamental shareholder value will never reach the full potential it should. If the CEO can't see that, he should be voted out.

    Basically, re-visit Good Company Fundamentals.

    As a side issue, a mediocre performance has no place here - I would strongly consider firing that moron that was not prepared and mentioned he had a "tired brain" during the last news conference. For a top executive in a major company to be unprepared - not having the simple number of OS is just pitiful. I would not want this lacky on my team. Then he makes a lame excuse of having a "tired brain " to an open news conference
    web cast. Just unforgivable.

  • crecy_war_knight by crecy_war_knight Aug 14, 2014 11:12 AM Flag

    B slapping you back to reality.

  • crecy_war_knight by crecy_war_knight Aug 14, 2014 11:06 AM Flag

    Afrezza is the validation of that technology. It is not a bock buster. But will get the ball rolling for new Revenue stream and is only the first of a line of inhaled products. This stock is no longer a speculative stock. Its a long term investment. So you own it- better get use to the term "dead money" at least till the sales numbers come in. It succeeded where PFE failed (so far). What is the next drug to get close to a NDA?

    This is about the future now, how about space suit inhaled meds - so your out on a long space walk and you get a severe muscle cramp...Well you can't reach in you pocket and take a pill, you can't give your self a shot....just push a button and inhaled anti cramp med shoots into your mouth. I might be ahead of my time?

  • Reply to

    Recommended at $4.00

    by kferriola Aug 6, 2014 8:16 PM
    crecy_war_knight crecy_war_knight Aug 13, 2014 10:32 AM Flag

    $4 or $14? ....Now in April it did get down to $15+ BRIEFLY. But that's it. It jumped right back to close about $18. You only get those opportunities ONCE. So I take it you're out at this point. As far as re-visiting the teens...I wish it would , not entirely impossible, but as each day goes by it will be harder and harder for that to happen. As it stays at any one level, it will tend to build Support. So good luck with trying to get back in at your number, but I think you missed the boat. This is why a wise ACAD trader, doesn't cash in ALL his/her shares...they have CORE HOLDINGS and some TRADING SHARES. Congrats on that great trade (wink) at $28, but if you are gonna wait till $4 or $ will NEVER get back in.

  • crecy_war_knight crecy_war_knight Aug 12, 2014 12:02 PM Flag

    but what color?

  • Reply to

    Awesome Mgmt Team!

    by opc11 Aug 12, 2014 11:54 AM
    crecy_war_knight crecy_war_knight Aug 12, 2014 11:57 AM Flag

    Oh i forgot...poor Matt has a tired Brain.

  • Reply to

    Awesome Mgmt Team!

    by opc11 Aug 12, 2014 11:54 AM
    crecy_war_knight crecy_war_knight Aug 12, 2014 11:56 AM Flag

    They screwed up this company and don't even realize it.

  • Reply to


    by rmul86 Aug 12, 2014 10:04 AM
    crecy_war_knight crecy_war_knight Aug 12, 2014 10:46 AM Flag

    I don't own any shares, but I think the low is in and hopefully up manana. The drug will not be a BlockBuster, but it shows the true value of the company - AFREZZA VALIDATES THE TECHNOLOGY. You'll most likely get your money back. I wouldn't sell and LOCK IN YOUR LOSSES.

  • Reply to


    by crecy_war_knight Aug 12, 2014 10:34 AM
    crecy_war_knight crecy_war_knight Aug 12, 2014 10:40 AM Flag

    Using Candlestick numbers approx $11.50 and $4.50 I got a Full Fib retrace of $ 7.23. Todays range so far,7.22 - 8.27.

  • crecy_war_knight by crecy_war_knight Aug 12, 2014 10:34 AM Flag

    So for "fun" I calculated a full Fib Retrace ( 61%)using a bottom of $5.25 and a top of $11(line chart) and I got $7.49, its already past that so you might be looking at the bottom. Gonna check the candlestick numbers.

  • crecy_war_knight by crecy_war_knight Aug 12, 2014 10:26 AM Flag


  • Reply to

    More Disappointment & more BAGHOLDERS.

    by crecy_war_knight Aug 11, 2014 3:28 PM
    crecy_war_knight crecy_war_knight Aug 12, 2014 10:19 AM Flag

    Was I right on or what....MORE BAGHOLDERS...

  • Reply to


    by tblant2000 Aug 11, 2014 5:40 PM
    crecy_war_knight crecy_war_knight Aug 12, 2014 9:29 AM Flag

    1 Million PD patients in the USA only. 40% will develop PDP at some point, some say less. OK, what ? 20%, But i still don't see the "losing bet".., PDP is late stage for PD patients. A fair % that get started on the drug will remain on the drug- its safe and effective. So the number of patients will be accumulative. The number will grow every year. Besides for the first year or so you don't expect to see full penetration of the drug in the PDP " market ". I am thinking first Q maybe 10-20% penetration. So (cost of the drug for 90days) x (0.2) x (total number of patients with PDP) = $ for first Q, subsequent formulas will see a spike in the penetration. Lets say it's 20,000 patients total this year (kinda like a worst case scenario, pick the lowest number ) that need Rx. So 1st Q, 20,000 x 0.2(20% penetration) = 4000 patients x ( drug cost for 90days) = total sales for 1st Q. So the key here is what will the drug cost. Lets say cost is $ 30/day. So 4000 patients x 90 days x $30/day =
    $10.8 MILLION...1stQ. Thats approx what I would expect. $10-20 mill for the 1st Q. Now as each Q rolls by the penetration will dramatically rise. Now if we are talking 2-400,000 patients...well I can't count that high. The EU has about 1.6 Million PD patients, you could consider maybe another 600,000 that will need treatment at some point.

  • Reply to


    by tblant2000 Aug 11, 2014 5:40 PM
    crecy_war_knight crecy_war_knight Aug 12, 2014 8:42 AM Flag

    Google this- What You Need to Know About Psychosis in Parkinson’s Disease

  • Reply to

    Diluted share count

    by cedafuntennis Aug 11, 2014 5:52 PM
    crecy_war_knight crecy_war_knight Aug 11, 2014 5:56 PM Flag

    Its one thing to not have the number on hand ( and why not?) , but its another thing to make a lame excuse. He should be fired, he really looks incompetent.

  • crecy_war_knight by crecy_war_knight Aug 11, 2014 5:33 PM Flag


  • Reply to

    Worst Successful Biotech of All Time?

    by jhn_lundgren Aug 11, 2014 4:58 PM
    crecy_war_knight crecy_war_knight Aug 11, 2014 5:30 PM Flag

    Look the point is the drug is NOT a block will not have ginormous sales - the value of this drug is the validation of the technology- not a drug that might get sales of 1% of the diabetic market.

  • Reply to

    Where is Dr. Mann and Hakan?

    by boomerp73 Aug 11, 2014 5:21 PM
    crecy_war_knight crecy_war_knight Aug 11, 2014 5:22 PM Flag

    He is on his way to the Cayman's

103.85+0.64(+0.62%)9:38 AMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.